Treatment
Dapagliflozin
4
Conditions
131
Trials
295K
Participants
65%
Average Safety
Condition Evidence
Alcoholic cardiomyopathy
20 trials · 20K participants
80% effectiveness · 65% safety
Chronic kidney disease due to diabetes mellitus type 1
1 trials · 100K participants
88% effectiveness · 65% safety
Chronic kidney disease due to diabetes mellitus type 2
1 trials · 150K participants
92% effectiveness · 65% safety
Heart Failure
109 trials · 25K participants
88% effectiveness · 65% safety